Barinthus Biotherapeutics Plc (BRNS)
0.7401
-0.02
(-2.49%)
USD |
NASDAQ |
Sep 08, 16:00
0.7628
+0.02
(+3.07%)
After-Hours: 20:00
Barinthus Biotherapeutics Total Liabilities (Quarterly) : 24.76M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.76M |
| March 31, 2026 | 25.66M |
| December 31, 2025 | 31.08M |
| September 30, 2025 | 24.64M |
| June 30, 2025 | 27.08M |
| March 31, 2025 | 26.40M |
| December 31, 2024 | 40.00M |
| September 30, 2024 | 29.23M |
| June 30, 2024 | 29.96M |
| March 31, 2024 | 27.47M |
| December 31, 2023 | 38.69M |
| Date | Value |
|---|---|
| September 30, 2023 | 34.37M |
| June 30, 2023 | 28.67M |
| March 31, 2023 | 28.25M |
| December 31, 2022 | 35.94M |
| September 30, 2022 | 31.33M |
| June 30, 2022 | 30.29M |
| March 31, 2022 | 32.99M |
| December 31, 2021 | |
| September 30, 2021 | 14.10M |
| June 30, 2021 | 9.927M |
| March 31, 2021 | 10.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 241.96M |
| Autolus Therapeutics Plc | 418.39M |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Adaptimmune Therapeutics Plc | 201.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.89M |
| Shareholders Equity (Quarterly) | 57.07M |
| Debt to Equity Ratio | 0.1804 |
| Current Ratio | 5.539 |
| Net Debt Paydown Yield | 1.20% |